HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Sidney H Kennedy Selected Research

Escitalopram

1/2022Pain severity and pain interference during major depressive episodes treated with escitalopram and aripiprazole adjunctive therapy: a CAN-BIND-1 report.
1/2022Pretreatment anxious depression as a predictor of side effect frequency and severity in escitalopram and aripiprazole adjunctive therapy.
1/2022Males and females differ in reported sexual functioning with escitalopram treatment for major depressive disorder: A CAN-BIND-1 study report.
9/2021Impacts on Quality of Life with Escitalopram Monotherapy and Aripiprazole Augmentation in Patients with Major Depressive Disorder: A CAN-BIND Report.
1/2021Cognitive Outcomes with Sequential Escitalopram Monotherapy and Adjunctive Aripiprazole Treatment in Major Depressive Disorder: A Canadian Biomarker Integration Network in Depression (CAN-BIND-1) Report.
1/2021Cognition and Its Association with Psychosocial and Occupational Functioning during Treatment with Escitalopram in Patients with Major Depressive Disorder: A CAN-BIND-1 Report: La Cognition Et Son Association Avec Le Fonctionnement Psychosocial Et Professionnel Durant Le Traitement Par Escitalopram Chez Des Patients Souffrant De Trouble Dépressif Majeur: Une Étude Can-Bind-1.
1/2021Predictors of Quality of Life Improvement with Escitalopram and Adjunctive Aripiprazole in Patients with Major Depressive Disorder: A CAN-BIND Study Report.
1/2020Association Between Side Effects and Blood microRNA Expression Levels and Their Targeted Pathways in Patients With Major Depressive Disorder Treated by a Selective Serotonin Reuptake Inhibitor, Escitalopram: A CAN-BIND-1 Report.
1/2020Escitalopram ameliorates differences in neural activity between healthy comparison and major depressive disorder groups on an fMRI Emotional conflict task: A CAN-BIND-1 study.
1/2020Symptom Dimension of Interest-Activity Indicates Need for Aripiprazole Augmentation of Escitalopram in Major Depressive Disorder: A CAN-BIND-1 Report.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Sidney H Kennedy Research Topics

Disease

101Major Depressive Disorder (Major Depressive Disorders)
11/2022 - 01/2003
29Bipolar Disorder (Manic Depressive Psychosis)
06/2022 - 06/2002
22Mood Disorders (Mood Disorder)
01/2022 - 11/2002
22Treatment-Resistant Depressive Disorder
01/2022 - 08/2002
15Mental Disorders (Mental Disorder)
01/2022 - 01/2002
11Anhedonia
01/2022 - 08/2014
9Mania (Manias)
12/2021 - 01/2005
9Inflammation (Inflammations)
01/2021 - 08/2007
8Depressive Disorder (Melancholia)
06/2019 - 11/2002
8Weight Gain
05/2016 - 08/2003
6Obesity
05/2016 - 04/2005
5Anxiety Disorders (Anxiety Disorder)
11/2020 - 01/2003
5Metabolic Syndrome (Dysmetabolic Syndrome X)
01/2012 - 02/2003
4Diabetes Mellitus
11/2010 - 04/2005
3Substance-Related Disorders (Drug Abuse)
01/2021 - 09/2007
3Fatigue
01/2018 - 01/2008
3Body Weight (Weight, Body)
09/2013 - 02/2003
2Alzheimer Disease (Alzheimer's Disease)
01/2021 - 08/2007
2Neuroinflammatory Diseases
01/2021 - 05/2016
2Psychotic Disorders (Schizoaffective Disorder)
01/2021 - 12/2019
2Alcoholism (Alcohol Abuse)
11/2020 - 09/2007
2Neurobehavioral Manifestations
10/2019 - 01/2017
2Schizophrenia (Dementia Praecox)
05/2016 - 01/2015
2Sleep Deprivation
01/2016 - 10/2009
2Insulin Resistance
02/2010 - 01/2006
2Sleepiness
12/2009 - 02/2009
2Overweight
09/2007 - 04/2005
1Social Phobia
04/2022
1Pain (Aches)
01/2022
1Anorexia Nervosa
01/2022
1Morbid Obesity
10/2021
1Hypertension (High Blood Pressure)
01/2021
1Cerebrovascular Disorders (Cerebrovascular Occlusion)
01/2021
1Cardiovascular Diseases (Cardiovascular Disease)
01/2021
1Genetic Risk Score
01/2021
1Stroke (Strokes)
01/2021

Drug/Important Bio-Agent (IBA)

63Antidepressive Agents (Antidepressants)IBA
01/2022 - 08/2002
16Biomarkers (Surrogate Marker)IBA
11/2022 - 10/2011
16EscitalopramFDA Link
01/2022 - 03/2006
12Antipsychotic Agents (Antipsychotics)IBA
01/2017 - 01/2003
11Aripiprazole (Abilify)FDA Link
01/2022 - 05/2009
8Glucose (Dextrose)FDA LinkGeneric
01/2022 - 04/2005
8Selective Serotonin Reuptake Inhibitors (Serotonin Reuptake Inhibitors)IBA
01/2020 - 08/2003
8agomelatine (S20098)IBA
10/2018 - 08/2007
7Valproic Acid (Depakote)FDA LinkGeneric
12/2021 - 02/2003
7LithiumIBA
01/2018 - 02/2003
7Olanzapine (Zyprexa)FDA Link
05/2016 - 08/2003
6Biological ProductsIBA
01/2021 - 12/2006
6Duloxetine Hydrochloride (Cymbalta)FDA Link
01/2019 - 02/2008
6Insulin (Novolin)FDA Link
03/2017 - 08/2007
6Venlafaxine Hydrochloride (Effexor)FDA LinkGeneric
08/2010 - 08/2003
5KetamineFDA LinkGeneric
01/2022 - 05/2016
5Quetiapine Fumarate (Seroquel)FDA Link
01/2018 - 12/2006
5Bupropion (Wellbutrin)FDA LinkGeneric
12/2014 - 06/2002
4Procainamide (Procan)FDA LinkGeneric
10/2021 - 01/2018
4Pharmaceutical PreparationsIBA
11/2020 - 02/2006
4Risperidone (Risperdal Consta)FDA LinkGeneric
01/2018 - 08/2003
4Interleukin-6 (Interleukin 6)IBA
01/2017 - 01/2015
4Serotonin (5 Hydroxytryptamine)IBA
03/2013 - 01/2003
4Lamotrigine (Lamictal)FDA LinkGeneric
02/2013 - 01/2005
4Fluoxetine (Prozac)FDA LinkGeneric
08/2010 - 01/2006
33,4-methylenedioxyethamphetamine (MDEA)IBA
01/2020 - 02/2015
3Modafinil (Provigil)FDA Link
10/2019 - 05/2009
3Proteins (Proteins, Gene)FDA Link
05/2017 - 07/2011
3CholesterolIBA
01/2012 - 07/2006
3Testosterone (Sustanon)FDA Link
02/2010 - 02/2003
2asenapineFDA Link
12/2021 - 01/2018
2cariprazineIBA
12/2021 - 01/2018
2BenzodiazepinesIBA
01/2020 - 11/2015
2CytokinesIBA
01/2017 - 05/2016
2Minocycline (Cyclops)FDA LinkGeneric
01/2017 - 12/2012
2Omega-3 Fatty Acids (Omega 3 Fatty Acids)IBA
01/2016 - 10/2009
2S-Adenosylmethionine (Ademetionine)IBA
01/2016 - 10/2009
2Interleukin-2 (IL2)IBA
11/2015 - 01/2015
2Brain-Derived Neurotrophic Factor (BDNF)IBA
11/2015 - 01/2015
2Methylphenidate (Ritalin)FDA LinkGeneric
12/2014 - 01/2008
2Adenosine Triphosphate (ATP)IBA
01/2012 - 11/2010
2NexusIBA
06/2011 - 02/2010
2CitalopramFDA LinkGeneric
08/2010 - 01/2009
2LipidsIBA
12/2009 - 07/2006
2Paroxetine (Paxil)FDA LinkGeneric
01/2009 - 03/2006
2Mirtazapine (Rexer)FDA LinkGeneric
02/2008 - 07/2006
2Hypoglycemic Agents (Hypoglycemics)IBA
10/2007 - 07/2006
2GlucocorticoidsIBA
10/2007 - 08/2007
2Illicit Drugs (Recreational Drugs)IBA
09/2007 - 09/2007
2nefazodone (Serzone)FDA LinkGeneric
01/2005 - 08/2003
1EndocannabinoidsIBA
11/2022
1mesoglycanIBA
06/2022
1Protons (Proton)IBA
04/2022
1Anesthetics (Anesthetic Agents)IBA
01/2022
1Nitrous Oxide (Laughing Gas)IBA
01/2022
1Long Noncoding RNAIBA
01/2021
1Proteasome Endopeptidase Complex (Proteasome)IBA
01/2021
1UbiquitinIBA
01/2021

Therapy/Procedure

22Therapeutics
01/2022 - 06/2002
15Drug Therapy (Chemotherapy)
01/2022 - 01/2005
14Deep Brain Stimulation
01/2022 - 03/2005
8Transcranial Magnetic Stimulation
11/2021 - 08/2014
3Complementary Therapies (Alternative Medicine)
01/2018 - 10/2009
1Electrodes (Electrode)
01/2022